Mohammad-Ali Yazdani Abyaneh

Mohammad-Ali Yazdani Abyaneh practices at Slocum-Dickson Medical Group - New Hartford in New Hartford, New York.

Mohammad-Ali Yazdani Abyaneh's NPI, 1508252784, was assigned on April 14, 2015. Mohammad-Ali Yazdani Abyaneh graduated from Albany Medical College in 2015. Mohammad-Ali Yazdani Abyaneh holds New York license 299230.

Mohammad-Ali Yazdani Abyaneh's primary practice is Slocum-Dickson Medical Group - New Hartford, at 1729 Burrstone Rd, New Hartford, NY 13413. The practice phone is (315) 798-1465.

Mohammad-Ali Yazdani Abyaneh's primary practice is Slocum-Dickson Medical Group - New Hartford in New Hartford, New York. Mohammad-Ali Yazdani Abyaneh is also affiliated with Wynn Hospital. The medical group on file is Slocum-Dickson Medical Group. Dmand AI also links Mohammad-Ali Yazdani Abyaneh to 1 more physician office and 1 group practice or clinic, each named with a free account. Mohammad-Ali Yazdani Abyaneh's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Mohammad-Ali Yazdani Abyaneh practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Mohammad-Ali Yazdani Abyaneh's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Mohammad-Ali Yazdani Abyaneh is licensed in New York.

CMS data shows 3,788 Medicare services from Mohammad-Ali Yazdani Abyaneh across 19 procedure codes in 2024, for 834 Medicare patients. Medicare paid $172,594 for them. Every service was in an office.

CMS counts 834 Medicare patients who saw Mohammad-Ali Yazdani Abyaneh in 2024. The largest group is 65 to 74, with 356 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mohammad-Ali Yazdani Abyaneh's median patient age at 66, with 51% women.

In 2024, Mohammad-Ali Yazdani Abyaneh wrote 1,964 Medicare Part D claims for 580 patients. 91% of them were for generic drugs. CMS names the drug for 1,769 of them, across 30 drugs with 11 or more claims each, at $787,936 in total drug cost. In 2023, CMS named 1,647 claims across 28 drugs.

Mohammad-Ali Yazdani Abyaneh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,476 procedures of removal of skin lesions by Mohammad-Ali Yazdani Abyaneh, more than 96% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Mohammad-Ali Yazdani Abyaneh, published from 2014 to 2019. 2015 was the busiest year, with 7. The most frequent topics are Skin Neoplasms, Dermatology and Forehead. Mohammad-Ali Yazdani Abyaneh has published most often in J Invest Dermatol. Mohammad-Ali Yazdani Abyaneh's most frequent co-authors are Robert Denison Griffith, MD, Leyre Ainara Falto Aizpurua, MD and Keyvan Nouri, MD.

CMS Open Payments shows 317 general payments to Mohammad-Ali Yazdani Abyaneh from 26 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $2,245.

Mohammad-Ali Yazdani Abyaneh graduated from Albany Medical College in 2015.